Asset manager names a drug stock he likes even more than Pfizer

Phil Blancato of Ladenburg Thalmann Asset Management talks about a stock that he thinks is a better play than Pfizer in the pharmaceutical sector. He also discusses how much upside he thinks the S&P 500 has before the year ends.